Cancer Research Targets Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 59, 6038-6041, December 1, 1999]
© 1999 American Association for Cancer Research
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawai, H.
Right arrow Articles by Suzuki, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawai, H.
Right arrow Articles by Suzuki, F.
[Cancer Research 59, 6038-6041, December 15, 1999]
© 1999 American Association for Cancer Research

Advances in Brief

Down-Regulation of Nuclear Factor {kappa}B Is Required for p53-dependent Apoptosis in X-Ray-irradiated Mouse Lymphoma Cells and Thymocytes1

Hidehiko Kawai, Yukiko Yamada, Masaaki Tatsuka, Ohtsura Niwa, Ken-ichi Yamamoto and Fumio Suzuki2

Department of Regulatory Radiobiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553 [H. K., Y. Y., M. T., F. S.]; Radiation Biology Center, Kyoto University, Kyoto 606-8501 [O. N.]; and Cancer Research Institute, Kanazawa University, Kanazawa 920-0934 [K-i. Y.], Japan


   ABSTRACT
Top
 ABSTRACT
Introduction
 Materials and Methods
 Results and Discussion
 REFERENCES
 
Transcription factors p53 and nuclear factor {kappa}B (NF-{kappa}B) have been implicated in apoptosis induced by DNA-damaging agents, but the relationship between these two factors at the molecular level is largely unknown. We have isolated apoptosis-resistant mutant sublines from a radiosensitive mouse lymphoma 3SB cell line that undergoes p53-depen-dent apoptosis after X-ray irradiation, and we have analyzed the NF-{kappa}B activity. Two of these apoptosis-resistant sublines expressed mutant p53 protein and exhibited a defect in the induction of cyclin-dependent kinase inhibitor p21 after X-ray irradiation. A decrease in the DNA binding activity of NF-{kappa}B was observed in the parental 3SB cells after exposure to X-rays, whereas the same activity was unaffected by radiation in the two mutant sublines. A similar down-regulation of NF-{kappa}B activity by X-rays was observed in thymocytes derived from p53 wild-type and heterozygous mice, but not in thymocytes from p53 homozygous knockout mice. These results suggest that NF-{kappa}B inactivation is p53 dependent and is required for X-ray-induced apoptosis in thymic lymphoma cells and normal thymocytes.


   Introduction
Top
 ABSTRACT
 Introduction
Materials and Methods
 Results and Discussion
 REFERENCES
 
Apoptosis is an active process of selective cell killing in the thymus in which T and B cells respond to intercellular or intracellular signals . In the previous study (1) , we found that 3SB, a thymic lymphoma cell line that expresses wild-type p53 protein, exhibited apoptosis shortly after exposure to X-rays. Five clonal sublines were isolated from the 3SB cells after mutagen treatment and repeated exposure to X-rays, and these sublines were refractory to X-ray-induced apoptosis. Interestingly, two of the five mutant sublines carried a mutation in the p53 gene. Studies of apoptotic response in thymocytes isolated from p53 knockout mice demonstrated that p53 is required for the induction of apoptosis after treatment with DNA-damaging agents such as {gamma}-rays and etoposide but not after treatment with glucocorticoids or calcium (2 , 3) . This indicates the existence of p53-dependent and -independent apoptosis pathways in normal thymocytes, which are triggered by different external signals.

Miyashita et al. (4) exploited the temperature-sensitive p53 gene and demonstrated that p53 activates transcription of the proapoptotic factor bax but represses bcl-2 in M1 leukemia cells. p53 has also been reported to enhance the expression of the apoptosis-inducing membrane receptor Fas (5) and to induce PAG608 (6) and p85 (7) , genes that may play a role in mediating apoptotic cell death. Using a comprehensive technique that allows quantitative evaluation of gene expression, Polyak et al. (8) examined new p53-dependent transcripts and identified 14 genes, named p53-induced genes, that were directly trans-activated by p53 before apoptosis. In addition to the transactivation-dependent pathway, p53 may participate in apoptosis by posttranslational modifications (9) that affect the stability and binding capability of p53 protein (10) .

The function of transcription factor NF-{kappa}B3 is tightly controlled by the cytoplasmic factor I{kappa}B{alpha} (see Ref. 11 for a review) and can be modulated by various proinflammatory cytokines, such as TNF-{alpha}, and genotoxic agents, such as ionizing radiation and UV irradiation. It has recently been shown that inactivation of NF-{kappa}B by a variety of external stimuli leads to apoptotic cell death, indicating an antiapo-ptotic function of NF-{kappa}B (12, 13, 14) . A similar protective function of NF-{kappa}B was reported in the E1A-mediated sensitization of radiation-induced apoptosis in human ovarian carcinoma cells (15) and in {gamma}-ray-induced apoptosis in normal human fibroblasts, but not in radiosensitive fibroblasts derived from AT patients (16) .

Although NF-{kappa}B and p53 have been implicated in radiation-induced apoptosis, functional interaction between these two factors is largely unknown. We therefore examined the p53 dependence of NF-{kappa}B inactivation during X-ray-induced apoptosis using a series of mouse lymphoma cell lines and mouse thymocytes derived frrom p53 knockout mice.


   Materials and Methods
Top
 ABSTRACT
 Introduction
 Materials and Methods
Results and Discussion
 REFERENCES
 
Cell Lines and Culture.
In this study, we used the mouse thymic lymphoma 3SB cell line and five apoptosis-resistant sublines (1B1C4, 1A1-6, 1A3-4, 1D5-8, and 2A1-1) that had been isolated from 3SB cells through a round of extensive mutagenesis and selection by radiation (1) . As described previously (1) , the cells were grown in suspension in DMEM supplemented with 10% fetal bovine serum and irradiated with X-rays.

Preparation of Thymocytes from p53 Knockout Mice.
The p53-deficient mouse was originally produced by the introduction of a neo gene fragment into the p53 gene locus in a ES line derived from a F1 mouse between the C57BL/6 and CBA strains (17) . This knockout mouse was back-crossed to C57BL/6N mice for 25 generations. Male and female mice with the genotype of p53 (KO/+) were mated, and the offspring were genotyped as p53 (KO/KO), p53 (KO/+), and p53 (+/+). Thymocytes were isolated from the mice at the age of 4–6 weeks old and suspended in RPMI 1640 supplemented with 10% fetal bovine serum. The cells were irradiated with X-rays and examined for apo-ptosis.

Apoptosis Assay.
X-irradiated cells were incubated in growth medium for various intervals after irradiation and harvested by centrifugation at 600 x g. The cells were fixed in 1% glutaraldehyde, washed with PBS, and resuspended in PBS containing 1 mM Hoechst 33342. After incubation at room temperature for 15 min, at least 600 or more stained cells were counted under a Zeiss Axiovert 135M fluorescence microscope. In the case of thymocytes, we used the dye exclusion test, in which the cells were stained with erythrosin B to score nonviable cells, as described in our previous report (1) .

Western Blot Analysis.
Whole cell extract and cytoplasmic extract were prepared as described previously (1) . These extracts were electrophoresed on 10% SDS-PAGE and transferred to Immobrin-P membrane (Millipore Corp., Bedford, MA). Western blotting was performed with the enhanced chemiluminescence system (Amersham Corp., Arlington Heights, IL) according to the protocols recommended by the manufacturer. Membranes were incubated with the appropriate antibody: (a) anti-p53 polyclonal antibody FL-393; (b) anti-p21 monoclonal antibody F-5; (c) anti-NF-{kappa}B p65 polyclonal antibody C-20; or (d) anti-I{kappa}B{alpha} polyclonal antibody C-15 (Santa Cruz Biotechnology, Santa Cruz, CA).

EMSA for NF-{kappa}B DNA Binding.
Nuclear extracts were prepared as described previously (1) . An EMSA for NF-{kappa}B DNA binding was performed using the IL-6{kappa}B probe (GGGATTTTCCC) as described previously (18) . The nuclear extracts (usually 6 mg/reaction) were incubated with the 32P-labeled-probe in a 20-µl reaction mixture for 15 min at 20°C, and the reactions were then terminated by the addition of EDTA, SDS, and bromphenol blue. Reaction products were electrophoresed on a 4% polyacrylamide gel.


   Results and Discussion
Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results and Discussion
REFERENCES
 
To determine the frequency of apoptotic cells after X-rays, we stained the cells with Hoechst 33242 and examined the changes in nuclear morphology under a fluorescence microscope. Fig. 1a, A and BCitation , shows unirradiated parental 3SB cells and the radioresistant 1B1C4 subline; Fig. 1a, C and DCitation , shows 3SB and 1B1C4 cells at after X-ray irradiation with 5 Gy, respectively. Neither the unirradiated 3SB and 1B1C4 cells nor X-irradiated 1B1C4 cells exhibit nuclear condensation. In contrast to these cells, almost all X-irradiated 3SB cells show extensive nuclear condensation and fragmentation (Fig. 1aC)Citation . The percentage of 3SB cells exhibiting nuclear change increased with incubation time and reached about 95.2% at 12 h after X-ray irradiation (Fig. 1b)Citation . However, the 1B1C4 cells and the other four radioresistant sublines (1A1-6, 1A3-4, 1D5-8, and 2A1-1) showed a low frequency of apoptosis, ranging from 4.8–10.3% at 12 h of postirradiation incubation.



View larger version (50K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 1. Induction of apoptotic cell death in the 3SB cell line and mutant sublines. a, fluorescence microscopic photographs of 3SB and 1B1C4 cells. Nuclear morphology is shown in unirradiated 3SB cells (A), in unirradiated 1B1C4 cells (B), in X-irradiated 3SB cells (C), and in X-irradiated 1B1C4 cells (D). After irradiation with 5 Gy of X-rays, the cells were incubated for 6 h and stained with Hoechst 33258. b, time course of the appearance of apoptotic cells after 5 Gy of X-ray irradiation. The percentage of apoptotic cells was calculated as the percentage of cells with abnormal nuclear morphology in 3SB cells (•) and in five radioresistant sublines (1B1C4, {circ}; 1A1-6, {triangleup}; 1A3-4, {triangledown}; 1D5-8, {square}; 2A1-1, {diamond}). Each point represents the mean of two independent experiments.

 
In the previous study (1) , we demonstrated that two of five radioresistant sublines, 1B1C4 and 1D5-8, carried a point mutation from TCC (serine) to TTC (phenylalanine) at codon 238 in the tumor suppressor p53 gene. In addition to the mutant allele, the 1D5-8 subline carried the wild-type p53 gene and showed normal p53 function when irradiated with X-rays. However, the 1B1C4 subline completely lacked normal p53 activities. To confirm the p53 function in X-ray responses, we examined the levels of the cyclin-dependent kinase inhibitor, p21 protein, expressed in 3SB cells and in three radioresistant sublines (1B1C4, 1A1-6, and 1D5-8) after irradiation with 5 Gy of X-rays. Fig. 2Citation shows the changes in p21 protein levels at 1–6 h after exposure. Under the experimental conditions described in "Materials and Methods," we could not detect p21 protein in either cell line immediately after X-ray irradiation. In 3SB and 1A1-6 cells, the p21 protein levels increased with postirradiation incubation time, and a similar pattern was observed in X-irradiated 1A3-4 and 2A1-1 sublines (data not shown) . In contrast, the 1B1C4 subline showed no production of p21 protein, indicating a complete defect in p53 function. Furthermore, the expression of p21 in the 1D5-8 subline, which was shown to express both wild-type and mutant-type p53 proteins (1) , was not observed until 3 h after exposure and was detected at low levels thereafter. This may result from the dominant negative action of mutated p53 protein. At any rate, the Western blot analysis of p21 protein in X-irradiated cells indicates that the functional loss of p53 prevents apoptotic death in thymic lymphoma cells.



View larger version (48K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 2. Western blot analysis of the expression of p21 protein in 3SB, 1B1C4, 1A1-6, and 1D5-8 cells at various times after X-ray irradiation. The cells were unirradiated (0 h) or irradiated with 5 Gy of X-rays and harvested 1.5, 3.0, 4.5, and 6.0 h after exposure.

 
Transcription factor NF-{kappa}B has recently been shown to suppress apoptosis induced by TNF-{alpha}, ionizing radiation, or daunorubicin (12, 13, 14) . NF-{kappa}B protein function was analyzed in 3SB cells and the five mutant sublines by an EMSA of nuclear extracts from X-irradiated cells. The oligomer used was a 36-bp DNA synthetic fragment containing NF-{kappa}B binding sequences. As seen in Fig. 3ACitation , two NF-{kappa}B DNA binding activities were detected in nuclear extracts from 3SB cells and five apoptosis-resistant sublines immediately after irradiation with 5 Gy of X-rays. A similar NF-{kappa}B DNA binding pattern was also observed in the actively growing cells without X-ray irradiation (data not shown). These results indicate the existence of a constitutive activation of NF-{kappa}B in 3SB cells and five apoptosis-resistant sublines. As reported previously (14 , 15 , 18) , the two bands indicated by arrows represent the DNA-protein complexes of the RelA/p65 and p50 heterodimer and the p50 homodimer, respectively. Interestingly, although p53 wild-type cell lines such as 3SB, 1A1-6, 1A3-4, and 2A1-1 showed a significant decrease in NF-{kappa}B DNA binding activity after exposure to X-rays, there was no such change in the 1B1C4 and 1D5-8 sublines. However, as seen in Fig. 3BCitation , the levels of NF-{kappa}B protein in the cytoplasmic extracts were constant over the 3-h postirradiation periods in parental 3SB cells and the apoptosis-resistant 1B1C4 subline. Similarly, the I{kappa}B{alpha} protein was constantly expressed during a 1- or 3-h incubation after X-ray irradiation in 3SB cells or in the 1B1C4 subline, respectively (Fig. 3B)Citation . The decrease of I{kappa}B{alpha} in 3SB cells at 3 h after X-ray irradiation may result from a nonspecific protein degradation of dead cells accumulated in the X-irradiated cell population. A constant expression of both of the proteins was also observed in X-irradiated 1A1-6, 1A3-4, 1D5-8, and 2A1-1 sublines (data not shown). Thus, the difference in the NF-{kappa}B DNA binding activity among these cell lines cannot be ascribed to either the different amount of NF-{kappa}B or the varied degradation of I{kappa}B{alpha}. As described above, the 1B1C4 subline expresses no p21 because of its complete defect in p53 function, and the 1D5-8 subline exhibits a delayed, low expression of p21, possibly due to the mutated p53. However, the other three sublines showed a transient increase in p53 protein (1) and a significant induction of p21 transcripts after X-ray irradiation. The expression patterns of both of the proteins in these three sublines are the same as those in their parental 3SB cells. The finding that there is a good correlation between the expression of functional p53 and the down-regulation of NF-{kappa}B activity in the X-irradiated cells suggests that NF-{kappa}B plays a role in p53-dependent signaling pathways of X-ray-induced apoptosis in mouse thymic lymphoma cells.



View larger version (49K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 3. NF-{kappa}B DNA binding activity and the expression of NF-{kappa}B and I{kappa}B{alpha} in X-irradiated thymic lymphoma cells. a, changes in NF-{kappa}B DNA binding activity in 3SB cells and five radioresistant mutant cell lines during the incubation after X-ray irradiation. The cells were irradiated with 5 Gy of X-rays, and nuclear extracts were prepared immediately after irradiation or 0.5 and 3 h after exposure. DNA binding activity was analyzed by an EMSA as described in "Materials and Methods." b, Western blot analysis of the expression of NF-{kappa}B and I{kappa}B{alpha} in 3SB and 1B1C4 cells at various times after X-ray irradiation. The cells were irradiated with 5 Gy of X-rays, and cytoplasmic extracts were prepared immediately after irradiation or 0.5, 1.0, and 3.0 h after exposure.

 
To confirm the relationship between p53 and NF-{kappa}B in X-ray-induced apoptosis, p53-null thymocytes were examined. We isolated thymocytes from 4–6-week-old p53 (+/+), p53 (KO/KO), and p53 (KO/+) mice and irradiated them in vitro with X-rays. Thymocytes were cultured at 37°C and examined by erythrosin B staining to measure the proportion of dead cells and the NF-{kappa}B-DNA binding activity.

Fig. 4ACitation shows the time course of the appearance of apoptosis for thymocytes derived from mice of three genotypes during incubation after 5 Gy of X-ray irradiation. The percentage of p53 (+/+) thymocytes stained with erythrosin B increased rapidly with incubation time and reached about 35.8% at 12 h after X-ray irradiation. Consistent with previous findings (2 , 3) , thymocytes from p53 (KO/KO) homozygous null mice were extremely resistant to X-ray-induced apoptosis, whereas there was no difference in the induction of dye-stained cells between thymocytes from homozygous p53 (+/+) and heterozygous p53 (KO/+) mice. A similar p53 dependence in the induction of apoptosis was also observed when the changes in nuclear morphology were examined in X-irradiated thymocytes under the fluorescence microscope (data not shown). Using an EMSA, we analyzed the DNA binding ability of NF-{kappa}B protein in X-irradiated thymocytes. Nuclear extracts prepared immediately after irradiation from the thymocytes from p53 (+/+), p53 (KO/+), and p53 (KO/KO) mice showed two bands of NF-{kappa}B-DNA complexes (Fig. 4B)Citation . In addition, when unirradiated, these thymocytes exhibited a high intensity of NF-{kappa}B-DNA bands (data not shown), again indicating a constitutive activation of NF-{kappa}B in the mouse thymus. Two bands disappeared quickly during the incubation of p53 (+/+) and p53 (KO/+) thymocytes after 5 Gy of irradiation. Although a similar decrease in these two bands was noted in p53 (KO/KO), it was not as pronounced as that seen in p53 (+/+) and p53 (KO/+) thymocytes. These results confirm that p53 function is tightly coupled with down-regulation of NF-{kappa}B and further suggest that down-regulation of NF-{kappa}B is necessary for X-ray induction of p53-dependent apoptosis of normal thymocytes.



View larger version (42K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 4. Apoptosis and NF-{kappa}B activity in X-irradiated mouse thymocytes. a, time course of the appearance of apoptotic cells after X-ray irradiation with 5 Gy. The percentage of apoptotic cells was calculated as the percentage of cells stained with erythrosin B in thymocytes derived from p53 wild-type (+/+) (•), heterozygous (KO/+) ({circ}), and homozygous null (KO/KO) ({square}) mice. b, changes in NF-{kappa}B DNA binding activity in p53 wild-type (+/+), heterozygous (KO/+), and homozygous null (KO/KO) thymocytes during the incubation after X-ray irradiation. The freshly isolated thymocytes were irradiated with 5 Gy of X-rays, and nuclear extracts were prepared immediately after irradiation or 3, 6, and 12 h after exposure. DNA binding activity was analyzed by an EMSA as described in "Materials and Methods."

 
Inactivation of NF-{kappa}B has been shown to be required for the induction of apoptosis in a variety of cells by various genotoxic agents (12, 13, 14, 15, 16) , but the mechanisms by which the presence of NF-{kappa}B enhances cell survival have not been fully analyzed. Chu et al. (19) reported that c-IAP2, one of the cellular homologues to baculovirus inhibitors of apoptosis, was critically involved in TNF-{alpha}-induced apoptosis and exerted positive feedback control on NF-{kappa}B. IEX-1L, a long type of gene product generated from immediate early response gene IEX-1, has also been shown to block cell killing by TNF-{alpha} treatment (20) . Interestingly, Wang et al. (21) demonstrated that the activation of these apoptosis inhibitors and TNF receptor-associated factors 1 and 2, all of which are shown to be activated by NF-{kappa}B, functioned to suppress this type of apoptosis at the level of caspase 8. Recently, one prosurvival factor, Bcl-2 homologue Bfl-1/A1, was identified as a transcriptional target of NF-{kappa}B (22 , 23) . Because Bcl-2 family proteins are a key regulator of apoptotic response and the transcription of the Bfl-1/A1 gene is distinctly controlled by NF-{kappa}B, this transcription factor could be directly activated to inhibit apoptotic cell death.

ATM kinase, the gene product responsible for AT, is capable of phosphorylating p53 protein, and ATM kinase activity is enhanced in cells irradiated with ionizing radiation (21) . It has been established that p53 is located downstream of ATM in DNA damage-induced signaling pathways. Recently, Jung et al. (16) reported that cells from AT patients exhibited enhanced {gamma}-ray-induced apoptosis when under forced expression of a dominant negative form of I{kappa}B{alpha} and a subsequent impairment of NF-{kappa}B response to {gamma}-rays. Therefore, we postulate that NF-{kappa}B may play a protective role in radiation-induced apoptosis in human cells and that NF-{kappa}B may operate downstream of ATM-dependent regulation through p53.

The mechanism by which activation of p53 leads to the inactivation of NF-{kappa}B is unknown, but it may involve activation of the cytoplasmic inhibitor protein I{kappa}B{alpha} (11) or inactivation of NF-{kappa}B-interacting proteins such as p300 and CREB-binding protein (24) . In fact, Ravi et al. (25) and Webster and Perkins (26) recently demonstrated that both p53 and NF-{kappa}B (RelA/p65) interact with these transcriptional coactivator proteins, suggesting the existence of a transcriptional cross-talk between NF-{kappa}B and p53. Therefore, we assume that p53 may suppress the antiapoptotic activity of NF-{kappa}B by interacting with a variety of cellular proteins that either directly or indirectly regulate NF-{kappa}B function, depending on cell types and external stimuli. In this study, we demonstrated that X-ray-induced apoptosis in mouse thymocytes and thymic lymphoma cells could be partially attributed to the activation of p53, followed by the inactivation of NF-{kappa}B. To elucidate how activated p53 elicits the parallel inactivation of NF-{kappa}B would provide useful information to help understand the varying susceptibility among different tumor tissues to radiation-induced apoptosis.


   ACKNOWLEDGMENTS
 
We thank Drs. H. Hama-Inaba, M. Muto, and H. Ohyama for the kind gift of the 3SB cell line and Dr. H. Yajima for helpful suggestions.


   FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported by a Grant-In-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan and performed in part through the Radiation Carcinogenesis Research Foundation of Denkyo-ken in Japan. Back

2 To whom requests for reprints should be addressed, at the Department of Regulatory Radiobiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan. Phone: 81-82-257-5824; Fax: 81-82-257-5825; E-mail: fmsuzuki{at}ipc.hiroshima-u.ac.jp Back

3 The abbreviations used are: NF-{kappa}B, nuclear factor {kappa}B; TNF, tumor necrosis factor; ES, embryonic stem; KO, knockout; EMSA, electrophoretic mobility shift assay; AT, ataxia telangiectasia; CREB, cAMP-responsive element-binding protein. Back

Received 6/28/99. Accepted 10/29/99.


   REFERENCES
Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results and Discussion
 REFERENCES
 

  1. Kawai H., Kitamura Y., Nikaido O., Tatsuka M., Hama-Inaba H., Muto M., Ohyama H., Suzuki F. Isolation and characterization of apoptosis-resistant mutants from a radiosensitive mouse lymphoma cell line. Radiat. Res., 149: 41-51, 1998.[Medline]
  2. Lowe S. W., Schmitt E. M., Smith S. W., Osborne B. A., Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.[Medline]
  3. Clarke A. R., Purdie C. A., Harrison D. J., Morris R. G., Bird C. C., Hooper M. L., Wyllie A. H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.), 362: 849-852, 1993.[Medline]
  4. Miyashita T., Krajewski S., Krajewska M., Wang H. G., Lin H. K., Liebermann D. A., Hoffman B., Reed J. C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9: 1799-1805, 1994.[Medline]
  5. Owen-Schaub L. B., Zhang W., Cusack J. C., Angelo L. S., Santee S. M., Fujiwara T., Roth J. A., Deisseroth A. B., Zhang W. W., Kruzel E., Radinsky R. Wild-type human p53 and a temperature-sensitive mutant induce Fas/Apo-1 expression. Mol. Cell. Biol., 15: 3032-3040, 1995.[Abstract]
  6. Israeli D., Tessler E., Haupt Y., Elkeles A., Wilder S., Amson R., Telerman A., Oren M. A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis. EMBO J., 16: 4384-4392, 1997.[Medline]
  7. Yin Y., Terauchi Y., Solomon G. G., Aizawa S., Rangarajan P. N., Yazaki Y., Kadowaki T., Barrett J. C. Involvement of p85 in p53-dependent apoptotic response to oxidative stress. Nature (Lond.), 391: 707-710, 1998.[Medline]
  8. Polyak K., Xia Y., Zweler J. L., Kinzler K. W., Vogelstein B. A model for p53-induced apoptosis. Nature (Lond.), 389: 300-305, 1997.[Medline]
  9. Haupt Y., Rowan S., Shaulian E., Vousden K. H., Oren M. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev., 9: 2170-2183, 1995.[Abstract/Free Full Text]
  10. Giaccia A. J., Kastan M. B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev., 12: 2973-2983, 1998.[Free Full Text]
  11. Verma I. M., Stevenson J. K., Schwarz E. M., Van Antwerp D., Miyamoto S. Rel/NF-{kappa}B/I{kappa}B family: intimate tales of association and dissociation. Genes Dev., 9: 2723-2735, 1995.[Free Full Text]
  12. Beg A. A., Baltimore D. An essential role for NF-{kappa}B in preventing TNF-{alpha}-induced cell death. Science (Washington DC), 274: 782-784, 1996.[Abstract/Free Full Text]
  13. Wang C. Y., Mayo M. W., Baldwin A. S., Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-{kappa}B. Science (Washington DC), 274: 784-787, 1996.[Abstract/Free Full Text]
  14. Van Antwerp D. J., Martin S. J., Kafri T., Green D. R., Verma I. M. Suppression of TNF-{gamma}-induced apoptosis by NF-{kappa}B. Science (Washington DC), 274: 787-789, 1996.[Abstract/Free Full Text]
  15. Shao R., Karunagaran D., Zhou B. P., Li K., Lo S. S., Deng J., Chiao P., Hung M. C. Inhibition of nuclear factor-{kappa}B activity is involved in E1A-mediated sensitization of radiation-induced apoptosis. J. Biol. Chem., 272: 32739-32742, 1997.[Abstract/Free Full Text]
  16. Jung M., Zhang Y., Dimtchev A., Dritschilo A. Impaired regulation of nuclear factor-{kappa}B results in apoptosis induced by gamma radiation. Radiat. Res., 149: 596-601, 1998.[Medline]
  17. Tsukada T., Tomooka Y., Takai S., Ueda Y., Nishikawa S., Yagi T., Tokunaga T., Takeda N., Suda Y., Abe S., Matsuo I., Ikawa Y., Aizawa S. Enhanced proliferative potential in culture of cells from p53-deficient. Oncogene, 8: 3313-3322, 1993.[Medline]
  18. Nakayama K., Shimizu H., Mimoto K., Watanabe T., Okamoto S., Yamamoto K. A lymphoid cell-specific nuclear factor containing c-rel-like protein preferentially interacts with interleukin-6 {kappa}B-related motifs whose activities are repressed in lymphoid cells. Mol. Cell. Biol., 12: 1736-1746, 1992.[Abstract/Free Full Text]
  19. Chu Z. L., McKinsey T. A., Liu L., Gentry J. J., Malim M. H., Ballard D. W. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-{kappa}B control. Proc. Natl. Acad. Sci. USA, 94: 10057-10062, 1997.[Abstract/Free Full Text]
  20. Wu M. X., Ao Z., Prasad K. V. S., Wu R., Schlossman S. F. IEX-IL, an apoptosis inhibitor involved in NF-{kappa}B-mediated cell survival. Science (Washington DC), 281: 998-1001, 1998.[Abstract/Free Full Text]
  21. Wang C. Y., Mayo M. W., Korneluk R. G., Goeddel D. V., Baldwin A. S., Jr. NF-{kappa}B antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science (Washington DC), 281: 1680-1683, 1998.[Abstract/Free Full Text]
  22. Zong W. X., Edelstein L. C., Chen C., Bash J., Celinas C. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-{kappa}B that blocks TNF{alpha}-induced apoptosis. Genes Dev., 13: 382-387, 1999.[Abstract/Free Full Text]
  23. Grumont R. J., Rourke I. J., Gerondakis S. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev., 13: 400-411, 1999.[Abstract/Free Full Text]
  24. Perkins N. D., Felzien L. K., Betts J. C., Leung K., Beach D. H., Nabel G. J. Regulation of NF-{kappa}B by cyclin-dependent kinases associated with the p300 coactivator. Science (Washington DC), 275: 523-527, 1997.[Abstract/Free Full Text]
  25. Ravi R., Mookerjee B., van Hensbergen Y., Bedi G. C., Giordano A., El-Deiry W. S., Fuchs E. J., Bedi A. p53-mediated repression of nuclear factor-{kappa}B RelA via the transcriptional integrator p300. Cancer Res., 58: 4531-4536, 1998.[Abstract/Free Full Text]
  26. Webster G. A., Perkins N. D. Transcriptional cross talk between NF-{kappa}B and p53. Mol. Cell. Biol., 19: 3485-3495, 1999.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Bernal-Mizrachi, C. M. Lovly, and L. Ratner
The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas
PNAS, June 13, 2006; 103(24): 9220 - 9225.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Yada, N. Takamura, K. Inagaki-Ohara, M. K. O'Leary, C. Wasem, T. Brunner, D. R. Green, T. Lin, and M. J. Pinkoski
The Role of p53 and Fas in a Model of Acute Murine Graft-versus-Host Disease
J. Immunol., February 1, 2005; 174(3): 1291 - 1297.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
S. Rocha, A. M. Martin, D. W. Meek, and N. D. Perkins
p53 Represses Cyclin D1 Transcription through Down Regulation of Bcl-3 and Inducing Increased Association of the p52 NF-{kappa}B Subunit with Histone Deacetylase 1
Mol. Cell. Biol., July 1, 2003; 23(13): 4713 - 4727.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Chen, B. Shen, L. Xia, A. Khaletzkiy, D. Chu, J. Y. C. Wong, and J.-J. Li
Activation of Nuclear Factor {kappa}B in Radioresistance of TP53-inactive Human Keratinocytes
Cancer Res., February 1, 2002; 62(4): 1213 - 1221.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawai, H.
Right arrow Articles by Suzuki, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawai, H.
Right arrow Articles by Suzuki, F.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online